Trials / Completed
CompletedNCT02839304
Investigation of the Adagio Cryoablation System in Patients With Atrial Fibrillation
A Prospective, Multicenter Investigation of the Adagio Cryoablation System in Patients With Atrial Fibrillation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Adagio Medical · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to demonstrate the safety and feasibility of the Adagio Cryoablation System is subjects with Paroxysmal (PAF), Persistent (PsAF) and Long-Standing Persistent Atrial Fibrillation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Cryoablation System | Pulmonary Vein Isolation, Posterior Wall Isolation. May Include Mitral Line ablation, AF Driver ablation, and Cavo-tricuspid Isthmus ablation as indicated |
Timeline
- Start date
- 2016-07-01
- Primary completion
- 2020-03-31
- Completion
- 2021-03-31
- First posted
- 2016-07-20
- Last updated
- 2021-09-20
Locations
3 sites across 3 countries: Belgium, France, Netherlands
Source: ClinicalTrials.gov record NCT02839304. Inclusion in this directory is not an endorsement.